Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Age Related Macular Degeneration, Stargardt's Disease or Exudative Age-related Macular Degeneration
and you are
between 18 and 90
years old
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

This study is a Phase I/II , open label,non randomized, prospective study to determine the safety of human embryonic stem cell derived Retinal pigmented epithelium (hESC RPE) sub retinal injections versus hESC RPE seeded on a polymeric substrate implanted in the sub retinal space,

Provided treatments

  • Procedure: injection of hESC-RPE in suspension
  • Procedure: injection hESC-RPE seeded in a substrate
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02903576. The sponsor of the trial is Federal University of São Paulo and it is looking for 18 volunteers for the current phase.
Official trial title:
Stem Cell Derived Retinal Pigmented Epithelium Implantation in Patients With Outer Retinal Degenerations: Phase I/II Clinical Trial